Shares of Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as $35.37 and last traded at $34.55, with a volume of 350331 shares traded. The stock had previously closed at $31.80.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on the company. Wall Street Zen upgraded Zepp Health to a "hold" rating in a research report on Saturday. Fundamental Research set a $13.87 price target on Zepp Health and gave the company a "buy" rating in a research report on Tuesday, April 22nd.
View Our Latest Stock Report on ZEPP
Zepp Health Price Performance
The business has a 50-day simple moving average of $11.06 and a 200 day simple moving average of $5.63. The stock has a market cap of $485.61 million, a P/E ratio of -6.93 and a beta of 1.11. The company has a current ratio of 1.10, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31.
Zepp Health (NYSE:ZEPP - Get Free Report) last released its quarterly earnings results on Monday, May 19th. The company reported ($1.13) EPS for the quarter. The company had revenue of $38.54 million during the quarter. Zepp Health had a negative net margin of 38.81% and a negative return on equity of 24.19%.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
See Also
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.